Manuel Caruso

article Stock S, Fertig L, Menkhoff VD, Strzalkowski T, Caruso M, Kobold S

Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research

Methods Cell Biol 191 2025.

DOI PUBMED

article Nowill AE, Caruso M, de Campos-Lima PO

T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets

Front Immunol 14 2023.

DOI PUBMED

article Banerjee SL, Lessard F, Chartier FJM, Jacquet K, Osornio-Hernandez AI, Teyssier V, Ghani K, Lavoie N, Lavoie JN, Caruso M, Laprise P, Elowe S, Lambert JP, Bisson N

EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks

Cell Rep 40 (1), 2022.

DOI PUBMED

Chercheur universitaire
Axe Oncologie

Publications

Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research

Methods Cell Biol 191 2025.

T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets

Front Immunol 14 2023.

EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks

Cell Rep 40 (1), 2022.